PeptidePicker
Home/Peptides/N-Acetyl Selank Amidate
CognitiveResearch

N-Acetyl Selank Amidate

Also known as: NASA · Acetylated Selank

A chemically stabilized variant of Selank with dramatically longer half-life and deeper blood-brain barrier penetration for enhanced anxiolytic and cognitive effects.

Dr. Sarah Mitchell

Reviewed by Dr. Sarah Mitchell, PharmD, BCPS

Lead Researcher · 12+ years in peptide therapeutics

Half-Life

~60–90 minutes

Typical Dose

200–400 mcg

Administration

Intranasal or subcutaneous

Mechanism of Action

Stabilized Selank analog with capped N- and C-termini that resists enzymatic breakdown, providing sustained modulation of GABA and serotonin systems.

Key Research Areas

nootropicanxietyselankenhancedcognitive

Frequently Asked Questions

What is N-Acetyl Selank Amidate?
A chemically stabilized variant of Selank with dramatically longer half-life and deeper blood-brain barrier penetration for enhanced anxiolytic and cognitive effects.
How does N-Acetyl Selank Amidate work?
Stabilized Selank analog with capped N- and C-termini that resists enzymatic breakdown, providing sustained modulation of GABA and serotonin systems.
What is the recommended dosage for N-Acetyl Selank Amidate?
The typical research dosage is 200–400 mcg, administered via Intranasal or subcutaneous. Dosage protocols vary by study and should be determined by a qualified healthcare professional.
What is the half-life of N-Acetyl Selank Amidate?
The half-life of N-Acetyl Selank Amidate is approximately ~60–90 minutes. This affects dosing frequency and timing in research protocols.
Is N-Acetyl Selank Amidate FDA approved?
N-Acetyl Selank Amidate is currently classified as "Research" and is not FDA approved for general use. It is available for research purposes or through compounding pharmacies depending on your jurisdiction.

Research Disclaimer

The information provided about N-Acetyl Selank Amidate is for educational purposes only and is not intended as medical advice. Always consult a qualified healthcare professional before starting any peptide protocol. Products discussed have not been evaluated by the FDA unless explicitly noted.

Related Peptides in Cognitive